from the half year report in January - they are winning contracts, and have a large pipeline of leads with signifiucant opportunity to see Revenue/Cash rise in a large way
This should see the need for CR taken care of, with no dilution to holders and remain tightly held stock, definately trading that way
Ann: IDT Secures contract with Sanofi Australia, page-18
Add IDT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.005(4.35%) |
Mkt cap ! $42.17M | |||
| Open | High | Low | Value | Volume |
| 11.8¢ | 12.5¢ | 11.5¢ | $115.9K | 1.000M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 133430 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 78046 | 1 |
View Market Depth
| Last trade - 15.57pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
11.5¢ |
Change
0.005 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 12.0¢ | 12.0¢ | 11.5¢ | 356227 | ||
| Last updated 15.50pm 14/06/2024 ? | |||||
| IDT (ASX) Chart |